Myelofibrosis
Notes: Myelofibrosis NOS ; Secondary myelofibrosis NOS ; code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-) ; code for adverse effect, if applicable, to identify drug (T45.1X5) ; acute myelofibrosis (C94.4-) ; idiopathic myelofibrosis (D47.1) ; leukoerythroblastic anemia (D61.82) ; myelofibrosis with myeloid metaplasia (D47.4) ; myelophthisic anemia (D61.82) ; myelophthisis (D61.82) ; primary myelofibrosis (D47.1) ; the underlying disorder, such as: ; malignant neoplasm of breast (C50.-)
Post COVID-19 condition, unspecified Notes: Post-acute sequela of COVID-19 ; the specific condition related to…
Post COVID-19 condition Notes: Post-acute sequela of COVID-19 ; the specific condition related to COVID-19…
COVID-19 Notes: code to identify pneumonia or other manifestations, such as: ; pneumonia due to…
Vaping-related disorder Notes: Dabbing related lung damage ; Dabbing related lung injury ; E-cigarette, or…
Emergency use of U07 Notes: Dabbing related lung damage ; Dabbing related lung injury ;…
Dependence on other enabling machines and devices Notes: Dependence on machine or device NOS